All In MedTech

Device Trial Radar · NCT03511313

Renal Denervation With Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension

A Prospective, Multi-centers, Randomized, Controlled Study of Assessing the Safety and Efficacy of Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension

Last checked: Nov 20, 2026Latest source record: Apr 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 264 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

264

Planned (sponsor's estimate)

Start

Apr 11, 2018

Primary completion

Jun 2020

Study completion Sep 2020

Sponsor

Lead sponsor
Synaptic Medical CorporationNot on our public-company list
Sponsor type
Industry
First posted
Apr 27, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the safety and efficacy of renal denervation with sterile irrigated deflectable ablation catheter used in renal artery in primary hypertension in China.

Conditions

  • Primary Hypertension

Interventions

  • Renal denervationDevice

    After a renal angiography according to standard procedures, subjects are treated with renal denervation (with sterile irrigated deflectable ablation catheter in renal artery), if without renal anatomic abnormality not detected by Renal CT/CTA.

  • Renal angiographyDiagnostic test

    A renal angiography according to standard procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in daytime average systolic blood pressure as measured by 24-hour Ambulatory Blood Pressure MonitoringTime frame: from baseline to 3 months post-procedure

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.